Skip to content

The diagnostic efficacy of low-dose total-body PET / CT (uEXPLORER) images in pediatric tumors: a prospective study

The diagnostic efficacy of low-dose total-body PET / CT (uEXPLORER) images in pediatric tumors: a prospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036334
Enrollment
Unknown
Registered
2020-08-22
Start date
2020-08-17
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pediatric tumors

Interventions

Case series:N/A

Sponsors

Sun Yat-Sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Pathology: solid malignant tumor, the specific pathological type is not limited. 2. Aged Newborn -14 years old; 3. Have not received anti-tumor treatment; 4. ECOG score 0-1 points; 5. Hemoglobin (HGB) >=90 g/L, white blood cell (WBC) >=4x10^9/L, platelet (PLT) >=100x10^9/L; 6. Liver function: ALT, AST<2.5 ULN, total bilirubin<2 ULN; 7. Renal function: serum creatinine <1.5 ULN; 8. Fasting blood glucose <6.1 mmol/L; 9. The guardian voluntarily participated and signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Refusal or inability to sign informed consent to participate in the trial; 2. Patients who have undergone radiotherapy and chemotherapy; 3. Patients with significantly reduced heart, liver, lung, kidney and bone marrow functions; 4. Serious, uncontrolled medical illnesses and infections.

Design outcomes

Primary

MeasureTime frame
imaging quality;

Countries

China

Contacts

Public ContactWei Fan

Sun Yat-sen University Cancer Center

fanwei@sysucc.org.cn+86 13602883007

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026